We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Digital Pathology System Provides Exceptional Image Quality Within Seconds

By LabMedica International staff writers
Posted on 02 Aug 2022

A high-performance digital pathology system that delivers exceptional image quality within seconds is setting new standards for laboratories. More...

OptraSCAN’s (Sunnyvale, CA, USA) high-performance OS-Ultra product line of brightfield scanners has a loading capacity of 80 to 480 slides. With no-touch continuous loading, it scans tissues or cells with a 15 mm x 15 mm area at 40x magnification in less than 60 seconds. They produce high-resolution images that can be analyzed further with the help of OptraSCAN's artificial intelligence-based software. This platform is capable of scanning histopathology and cytopathology slides. In addition, it can be configured with 5 to 11 layers for volume scanning or viewed as composite, single layer, fully focused image.

The tray and basket system used by OS-Ultra scanners are designed to efficiently transfer and position slides for scanning and prevent slide handling mistakes. For organizations seeking to scale up operations by increasing throughput, OS Ultra is an efficient, consistent, and accurate solution. OptraSCAN has received CE-IVDR marking for the OS-Ultra scanners, which are available at an extremely affordable price point, including pay-per-scan based OPEX models. OptraSCAN's full digital pathology solutions include scanning devices, image management and viewing software, telepathology software, and image analysis solutions for biomarker and morphometry.

"The CE-IVDR mark will enhance the acceptability of OS-Ultra systems across the globe and strengthen OptraSCAN's mission to improve patient outcomes with affordable and easy to implement digital pathology solutions," said Abhi Gholap, Founder CEO of OptraSCAN.

Related Links:
OptraSCAN 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.